Drug Database
Back to search

Poland· PL-100246880

Arthryl

A glucosamine product containing glucosamini sulfas, registered in Poland by Cooper Consumer Health B.V.. The same ATC class is registered in 14 of our 19 countries.

ATC M01AX05

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedArthrylATCM01AX05REGISTER NO.PL-100246880PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about glucosamini sulfasAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Glucosamine is registered in 14 of 19 countries.

Countries holding a registration under ATC M01AX05 (glucosamine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose
Search glucosamine products by name

Glucosamine · ATC M01AX05

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of glucosamine costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Glucosamine · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

  • ES Spain$0.23
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Glucosamini sulfas
Manufacturer
Cooper Consumer Health B.V.
Country
Poland (PL)
ATC code
M01AX05
ATC class
Glucosamine
Defined daily dose
1.5 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909990772711
  • gtin
    04019338609287
  • gtin
    04019338609294
  • gtin
    08711744058746

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for glucosamine.

Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check glucosamine against other medicinesHow interaction checks work

Glucosamine · interactions on record

2 records

  • 2 moderate

Most severe, free to view

  • DicoumarolB01AA01moderate
  • WarfarinB01AA03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Glucosamine in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glucosamine products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Cyprus · Donarthril
  • Czechia · Artaxin, Flexove
  • Germany · Glucosamin Doppelherzpharma
  • Spain · Acenam, Duartron
  • Finland · Glucosamin Orion
  • France · Flexea, Osaflexan
  • United Kingdom (Northern Ireland) · Glucosamine Medley Pharma, Yointy
  • Greece · Donarot, Energorot
  • Hungary · Cartilamin, Glukozamin Pharma Nord
  • Ireland · Arthrimel, Dona
  • Iceland · Glucomed
  • Norway · Glucosamin Orifarm, Samin
  • Portugal · Biartril, Glucomed
  • Sweden · Artroxan, Glucomed
  • Slovakia · Glucomed

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a0fa4b42-40da-4d54-a77c-bd2a8f3b424c
GET /v1/drugs/a0fa4b42-40da-4d54-a77c-bd2a8f3b424c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek do sporządzania roztworu doustnego",
  "source": "urpl",
  "strength": "1500 mg",
  "packaging": "05909990772711 ¦ Rp ¦ 12278\n20 sasz. 1500 mg\n04019338609287 ¦ Rp ¦ Skasowane ¦ 127717\n30 sasz. 1500 mg\n04019338609294 ¦ Rp ¦ 127718\n90 sasz. 1500 mg\n08711744058746 ¦ Rp ¦ 165315\n30 sasz. 1500 mg",
  "substance": "Glucosamini sulfas 1500 mg",
  "common_name": "Glucosamini sulfas",
  "pl_product_id": "100246880",
  "pozwolenie_nr": "07727",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about glucosamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console